Community and Patient Preference Research

Community and Patient Preference Research specializes in eliciting patient, caregiver, healthcare professional, and community preferences using advanced choice-based measurement techniques. Their work informs therapy development from early innovation through market access by quantifying what stakeholders value in treatment attributes. They have developed digital tools like ChoiceApp to facilitate shared decision-making in clinical settings such as multiple myeloma. Their research supports pharmaceutical companies with evidence for regulatory submissions and health technology assessments[1][2][4][6]. Recent projects include preference studies for Alzheimer’s disease treatments on behalf of pharmaceutical clients such as Novo Nordisk[7].